Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced cardionecrosis.

T Godfraind

    Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Drug-induced cardiotoxicity, affecting cardiac function, can be reversible or irreversible. The heart’s condition influences toxicity, with calcium metabolism disturbances potentially treatable by calcium entry blockers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Calcium channel blockers and tissue remodeling in hypertension].

    Bulletin et memoires de l'Academie royale de medecine de Belgique·2002
    Same author

    Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats.

    British journal of pharmacology·2001
    Same author

    New insights into the therapeutic mechanism of action of calcium channel blockers in salt-dependent hypertension: their interaction with endothelin gene expression.

    Journal of cardiovascular pharmacology·2001
    Same author

    Lacidipine prevents endothelial dysfunction in salt-loaded stroke-prone hypertensive rats.

    Hypertension (Dallas, Tex. : 1979)·2001
    Same author

    Carvedilol and lacidipine prevent cardiac hypertrophy and endothelin-1 gene overexpression after aortic banding.

    Hypertension (Dallas, Tex. : 1979)·1999
    Same author

    Effect of nitro-L-arginine on electrical and mechanical responses to acetylcholine in the superior mesenteric artery from stroke-prone hypertensive rat.

    British journal of pharmacology·1999

    Area of Science:

    • Pharmacology
    • Cardiology
    • Toxicology

    Background:

    • Cardiotoxicity involves drug-induced cardiac dysfunction, ranging from temporary rhythm disturbances to irreversible damage (cardionecrosis).
    • The severity of cardiotoxicity is influenced by both drug potency and the heart's existing pathophysiological state.
    • Two main categories of cardiotoxicity exist, based on drug action on cellular structure or metabolic regulation.

    Purpose of the Study:

    • To categorize drug-induced cardiotoxicity based on mechanisms of action.
    • To highlight the role of the heart's functional state in drug cardiotoxicity.
    • To explore the potential of calcium entry blockers in preventing or treating specific types of cardiotoxicity.

    Main Methods:

    • Review of existing literature on drug-induced cardiotoxicity.

    Related Experiment Videos

  • Classification of cardiotoxic drugs based on their molecular targets (e.g., protein biosynthesis, metabolic regulation).
  • Analysis of the influence of cardiac pathophysiology on cardiotoxicity manifestation.

    • Main Results:

    • Drugs can impair cellular structure (e.g., anthracyclines) or metabolic regulation (e.g., sympathomimetics).
    • Cardiotoxicity mimicking anoxia/ischemia is linked to disturbances in cellular calcium metabolism.
    • Calcium entry blockers show potential for preventing/treating cardiotoxicity related to calcium metabolism disruption.

    Conclusions:

    • Drug cardiotoxicity mechanisms vary, impacting cellular structure or metabolic pathways.
    • Cardiac functional state significantly modulates cardiotoxicity, particularly for drugs affecting metabolic regulation.
    • Disturbances in cellular calcium metabolism are a key factor in certain cardiotoxicities, suggesting calcium entry blockers as a therapeutic strategy.